Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Metal Mediated Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109293513B reveals a novel metal-mediated route for Sitafloxacin Intermediate II, offering >96% yield and simplified purification for reliable API manufacturing.